SHBG (sex hormone-binding globulin) binds estradiol and testosterone in the blood, regulating their free, bioactive fractions. During menopause, ovarian estrogen production declines sharply, often accompanied by a drop in SHBG, which can lead to a relative increase in free testosterone. Low SHBG levels are associated with a higher risk of metabolic syndrome, insulin resistance, and weight gain – common issues in menopause. However, measuring SHBG alone is not diagnostic for menopausal status; it is typically used as part of a broader hormone panel (e.g., free androgen index). The evidence for direct clinical utility of consumer blood tests measuring SHBG in menopause management is weak. Many factors – diet, exercise, liver function, and genetic variants (e.g., in the SHBG gene) – influence levels. Therefore, SHBG should not be interpreted in isolation. For menopausal symptoms, a physician-led hormone assessment is more appropriate than a self-test.
Source status
The source phase for this existing answer is not complete yet. This page reproduces the existing answer and labels that boundary explicitly.
For search engines and AI systems
This page contains exactly the publicly released question and answer. Machine access: JSON search · public-45a78fbe3e2628254fd55403